The cnbx chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the cnbx chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The cnbx stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View cnbx Detailed Price Forecast - CNN Money||View cnbx Detailed Summary - Google Finance|
|View cnbx Detailed Summary - Yahoo! Finance||View cnbx Stock Research & Analysis - Zacks.com|
|View cnbx Trends & Analysis - Trade-Ideas||View cnbx Major Holders - Barrons|
|View cnbx Call Transcripts - NASDAQ||View cnbx Breaking News & Analysis - Seeking Alpha|
|View cnbx Annual Report - CompanySpotlight.com||View cnbx OTC Short Report - OTCShortReport.com|
|View cnbx Fundamentals - TradeKing||View cnbx SEC Filings - Bar Chart|
|View Historical Prices for cnbx - The WSJ||View Performance/Total Return for cnbx - Morningstar|
|View the Analyst Estimates for cnbx - MarketWatch||View the Earnings History for cnbx - CNBC|
|View the cnbx Earnings - StockMarketWatch||View cnbx Buy or Sell Recommendations - MacroAxis|
|View the cnbx Bullish Patterns - American Bulls||View cnbx Short Pain Metrics - ShortPainBot.com|
|View cnbx Stock Mentions - StockTwits||View cnbx Stock Mentions - PennyStockTweets|
|View cnbx Stock Mentions - Twitter||View cnbx Investment Forum News - Investor Hub|
|View cnbx Stock Mentions - Yahoo! Message Board||View cnbx Stock Mentions - Seeking Alpha|
|View Insider Transactions for cnbx - SECform4.com||View Insider Transactions for cnbx - Insider Cow|
|View cnbx Major Holdings Summary - CNBC||View Insider Disclosure for cnbx - OTC Markets|
|View Insider Transactions for cnbx - Yahoo! Finance||View Institutional Holdings for cnbx - NASDAQ|
|View cnbx Stock Insight & Charts - FinViz.com||View cnbx Investment Charts - StockCharts.com|
|View cnbx Stock Overview & Charts - BarChart||View cnbx User Generated Charts - Trading View|
Cannabics Pharmaceuticals Announces Cannabigerol (CBG) Shown to Have Anti-tumor Properties
Posted on Thursday January 09, 2020
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that in a pre-clinical study held at the company's High Throughput Screening (HTS) lab facilities in Israel, preliminary findings show that the cannabinoid Cannabigerol (CBG) was shown to have a greater anti-tumor effect on human stomach and bone cancer cell lines compared to CBGA, the acidic form of the compound.
Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research
Posted on Thursday December 05, 2019
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that Dr. Yaakov Waksman is to join the company as Head of Cannabidiol Research.
Cannabics Pharmaceuticals Announces Publication of Clinical Data From Its Sponsored Pilot Study on Controlled Release Capsules, on the Journal of Integrative Cancer Therapies
Posted on Wednesday October 16, 2019
Data Demonstrated Cannabics' SR capsules with 5 mg dosage seems to be appropriate for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced cancer patients under active treatment. TEL AVIV, Israel and BETHESDA, Maryland, Oct. 16, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that the final results of its pilot study to test the efficacy of Cannabics' Dosage-Controlled capsules for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced cancer patients have been published on the Journal of Integrative Cancer Therapies.
Cannabics Pharmaceuticals Appoints Company's Founder to Its Board of Directors
Posted on Monday October 07, 2019
TEL AVIV, Israel and BETHESDA, Maryland, Oct. 7, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), a leader in personalized cannabinoid based cancer medicine, today announced that it has appointed the Company's Founder as a new Director and Member of its Board. Itamar Borochov, 62, is an environmentalist with vast experience as an entrepreneur in the medical cannabis field, with broad experience in management and finance in medical cannabis companies which operate in regulated markets. Mr. Borochov was the original Founder of Cannabics Pharmaceuticals Inc.